Gosset, F.

patient heparin enoxaparin study infarction streptokinase group unfractionated heparin placebo unfractionated hospital therapy reperfusion placebo group heart resolution eur heart j tissue plasminogen activator efficacy artery event treatment thrombolysi aspirin infarct size patency angina 180 min death st-segment resolution trial safety st-segment infarct artery disease haemorrhage 90 min 30 days simoon fibrinolytic low-molecular-weight heparin grade outcome investigator reocclusion end-point amisk cardiology table angiography szpital randomized enoxaparin group st-segment elevation weight heparin disease activator timi frame count plasminogen comparison result reinfarction difference parameter tissue tenecteplase thrombolytic issue low-molecular-weight amisk study subcutaneou university ejection fraction committee randomised agent value regimen management number